Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its ...

MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...

For people who constantly think about what they are going to eat meal to meal, their food noise goes down significantly’ ...

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...

More people are reporting experiencing potentially dangerous side effects after using slimming drugs, the national toxicology ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

The number of people poisoned by the incorrect use of weight loss medication is on the rise in the Netherlands. Last year, ...

Weight loss drugs like Ozempic have gained a lot of popularity However these medications are not without side effects One ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...